Clinical Trial: A Single-Arm, Exploratory Clinical Study of Adebelimumab in Combination with the AG Regimen for the Treatment of Potentially Resectable Cholangiocarcinoma (China)

China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Single-Arm, Exploratory Clinical Study of Adebelimumab in Combination with the AG Regimen for the Treatment of Potentially Resectable Cholangiocarcinoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133648

Registration Time: 2026/09/30

Type: Interventional study

Primary Sponsor: Shandong Provincial Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=340053

Published by HT Digital Content Services with permission from Health Daily Digest....